Page last updated: 2024-08-23

ferric nitrilotriacetate and Carcinoma, Hepatocellular

ferric nitrilotriacetate has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonkovsky, HL; Hou, WH; Lambrecht, RW; Rossi, L; Shan, Y; Zheng, JY1
Brissot, P; Deugnier, Y; Dezier, JF; Lescoat, G; Loreal, O; Moirand, R; Pasdeloup, N1

Other Studies

2 other study(ies) available for ferric nitrilotriacetate and Carcinoma, Hepatocellular

ArticleYear
Iron increases HMOX1 and decreases hepatitis C viral expression in HCV-expressing cells.
    World journal of gastroenterology, 2009, Sep-28, Volume: 15, Issue:36

    Topics: Basic-Leucine Zipper Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Deferoxamine; Fanconi Anemia Complementation Group Proteins; Ferric Compounds; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Humans; Iron; Liver Neoplasms; NF-E2-Related Factor 2; Nitrilotriacetic Acid; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering; Viral Proteins

2009
Iron induction of ferritin synthesis and secretion in human hepatoma cell (Hep G2) cultures.
    Liver, 1989, Volume: 9, Issue:3

    Topics: Albumins; Carcinoma, Hepatocellular; Ferric Compounds; Ferritins; Humans; In Vitro Techniques; Iron; Liver Neoplasms; Nitrilotriacetic Acid; Prealbumin; Stimulation, Chemical; Transferrin; Tumor Cells, Cultured

1989